In order to investigate the involvement of TNK2 in the activation of the MEK/ERK signaling pathway by ZNF692, we altered the expression of TNK2 in osteosarcoma cells with either reduced or increased levels of ZNF692. This evidence concerns the gene ZNF692 and osteosarcoma.